109 related articles for article (PubMed ID: 8328242)
21. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
22. Pericellular lacunae in the diagnosis of metastatic carcinoma in effusions: is this a useful sign?
Thomson T; Hayes MM
Diagn Cytopathol; 1996 Sep; 15(3):193-6. PubMed ID: 8955600
[TBL] [Abstract][Full Text] [Related]
23. Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells.
Davidson B; Xi Z; Saatcioglu F
Diagn Cytopathol; 2007 Feb; 35(2):80-4. PubMed ID: 17230566
[TBL] [Abstract][Full Text] [Related]
24. Cytological diagnosis of serous effusions in a cancer hospital in Brazil.
Oyafuso MS; Longatto Filho A; Bortolan J; Rahal P; Bisi H; Lombardo V
Pathologica; 1996 Apr; 88(2):128-31. PubMed ID: 8927447
[TBL] [Abstract][Full Text] [Related]
25. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
26. Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis.
Parwani AV; Chan TY; Ali SZ
Cancer; 2004 Apr; 102(2):87-91. PubMed ID: 15098252
[TBL] [Abstract][Full Text] [Related]
27. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
28. Cytohistologic correlation of peritoneal washing cytology in gynecologic disease.
Zuna RE; Mitchell ML; Mulick KA; Weijchert WM
Acta Cytol; 1989; 33(3):327-36. PubMed ID: 2728787
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
30. False positive malignant peritoneal cytology and psammoma bodies in benign gynecologic disease.
Fanning J; Markuly SN; Hindman TL; Galle PC; McRae MA; Visnesky PM; Hilgers RD
J Reprod Med; 1996 Jul; 41(7):504-8. PubMed ID: 8829063
[TBL] [Abstract][Full Text] [Related]
31. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
32. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
33. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.
Eguchi H; Ohigashi H; Takahashi H; Yano M; Motoori M; Miyashiro I; Kishi K; Ohue M; Noura S; Seki Y; Yamada T; Goto K; Yamamoto T; Idota A; Fujii J; Nakajima H; Yamasaki T; Ishikawa O
Surgery; 2009 Nov; 146(5):888-95. PubMed ID: 19744431
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
35. [primary and secondary malignant liver tumors at autopsy, biopsy and cytology: frequency and problems of differential diagnosis].
Nizze H; Hebecker R; Stropahl G; Putzke HP; Barten M; Käckenmeister A
Verh Dtsch Ges Pathol; 1995; 79():137-43. PubMed ID: 8600678
[TBL] [Abstract][Full Text] [Related]
36. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
37. Telomerase activity in benign and malignant cytologic fluids.
Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ
Cancer; 1999 Apr; 87(2):93-9. PubMed ID: 10227600
[TBL] [Abstract][Full Text] [Related]
38. [Experiences with an enzyme cytochemical test for tumor cells in pleural fluid and ascites (author's transl)].
Eckert H; Wildner GP
Arch Geschwulstforsch; 1979; 49(4):305-10. PubMed ID: 496568
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
